Caricamento...
Safety and efficacy of insulin degludec/liraglutide (IDegLira) added to sulphonylurea alone or to sulphonylurea and metformin in insulin‐naïve people with Type 2 diabetes: the DUAL IV trial
AIM: To investigate the safety and efficacy of insulin degludec/liraglutide (IDegLira), a novel combination product, as add‐on therapy for people with Type 2 diabetes uncontrolled on sulphonylurea therapy. METHODS: In this 26‐week, double‐blind trial, adults with Type 2 diabetes [HbA(1c) 53–75 mmol/...
Salvato in:
| Pubblicato in: | Diabet Med |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley and Sons Inc.
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5811787/ https://ncbi.nlm.nih.gov/pubmed/27589252 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dme.13256 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|